Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Tumor-Derived Microvesicles From Sera of Patients with Acute Myeloid Leukemia Suppresses NK Cell Cytotoxicity Via Transforming Growth Factor Beta-1.

Miroslaw J Szczepanski, Marta E Szajnik, Malgorzata Czystowska, Magis Mandapathil, Ann Welsh, Theresa L Whiteside, Michael Boyiadzis

Blood (2009) 114 (22): 2678.

https://doi.org/10.1182/blood.V114.22.2678.2678

Published: 2009

Journal Articles

Mechanisms of Suppression Used by Regulatory T Cells in Patients Newly Diagnosed with Acute Myeloid Leukemia

Miroslaw J Szczepanski, Marta Szajnik, Malgorzata Czystowska, Magis Mandapathil, Ann Welsh, Kenneth Foon, Theresa L Whiteside, Michael Boyiadzis

Blood (2008) 112 (11): 2938.

https://doi.org/10.1182/blood.V112.11.2938.2938

Published: 2008

Journal Articles

The Role of Interleukin-15 on Natural Killer Cell Homeostasis and Activity in Patients with Acute Myeloid Leukemia

Mi roslaw J Szczepanski, Malgorzata Czystowska, Marta E Szajnik, Magis Mandapathil, Benedict Hilldorfer, Ann Welsh, Kenneth Foon, Theresa L Whiteside, Michael Boyiadzis

Blood (2008) 112 (11): 2574.

https://doi.org/10.1182/blood.V112.11.2574.2574

Published: 2008

Journal Articles

CD4+ CD25 high Regulatory T Cells in Newly Diagnosed Patients with Acute Myeloid Leukemia.

Miroslaw J. Szczepanski, MD, Laura Strauss, PhD, Malgorzata Czystowska, PhD, Marta Szajnik, MD, PhD, Ann Welsh, Kenneth A. Foon, MD, Theresa L. Whiteside, PhD, Michael Boyiadzis, MD

Blood (2007) 110 (11): 2835.

https://doi.org/10.1182/blood.V110.11.2835.2835

Published: 2007

Journal Articles

Interleukin-15 Upregulates the Expression of NK-Cell Activating Receptors and Concomitantly Increases the NK Cytotoxicity in Patients with Acute Myeloid Leukemia.

Miroslaw J. Szczepanski, MD, Malgorzata Czystowska, PhD, Marta Szajnik, MD, PhD, Ann Welsh, Kenneth A. Foon, MD, Theresa L. Whiteside, PhD, Michael Boyiadzis, MD

Blood (2007) 110 (11): 2298.

https://doi.org/10.1182/blood.V110.11.2298.2298

Published: 2007

NARROW

Tumor-Derived Microvesicles From Sera of Patients with Acute Myeloid Leukemia Suppresses NK Cell Cytotoxicity Via Transforming Growth Factor Beta-1.

Mechanisms of Suppression Used by Regulatory T Cells in Patients Newly Diagnosed with Acute Myeloid Leukemia

The Role of Interleukin-15 on Natural Killer Cell Homeostasis and Activity in Patients with Acute Myeloid Leukemia

CD4+ CD25 high Regulatory T Cells in Newly Diagnosed Patients with Acute Myeloid Leukemia.

Interleukin-15 Upregulates the Expression of NK-Cell Activating Receptors and Concomitantly Increases the NK Cytotoxicity in Patients with Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Tumor-Derived Microvesicles From Sera of Patients with Acute Myeloid Leukemia Suppresses NK Cell Cytotoxicity Via Transforming Growth Factor Beta-1.

Mechanisms of Suppression Used by Regulatory T Cells in Patients Newly Diagnosed with Acute Myeloid Leukemia

The Role of Interleukin-15 on Natural Killer Cell Homeostasis and Activity in Patients with Acute Myeloid Leukemia

CD4+ CD25 high Regulatory T Cells in Newly Diagnosed Patients with Acute Myeloid Leukemia.

Interleukin-15 Upregulates the Expression of NK-Cell Activating Receptors and Concomitantly Increases the NK Cytotoxicity in Patients with Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only